Aju IB Investment Co. Ltd (027360) - Total Liabilities
Based on the latest financial reports, Aju IB Investment Co. Ltd (027360) has total liabilities worth ₩75.93 Billion KRW (≈ $51.46 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Aju IB Investment Co. Ltd - Total Liabilities Trend (2016–2024)
This chart illustrates how Aju IB Investment Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. See Aju IB Investment Co. Ltd short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Aju IB Investment Co. Ltd Competitors by Total Liabilities
The table below lists competitors of Aju IB Investment Co. Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Envela Corp
NYSE MKT:ELA
|
USA | $32.07 Million |
|
Chengdu Jafaantai Technology Co Ltd
SHE:300559
|
China | CN¥370.50 Million |
|
Beta Bionics, Inc. Common Stock
NASDAQ:BBNX
|
USA | $33.17 Million |
|
Xinjiang Sailing Information Technology Co Ltd
SHE:300588
|
China | CN¥402.05 Million |
|
Financial Institutions Inc
NASDAQ:FISI
|
USA | $4.50 Billion |
|
Empresa Distribuidora y Comercializadora Norte S.A.
BA:EDN
|
Argentina | AR$3.61 Trillion |
|
Start Group
SHG:600734
|
China | CN¥1.20 Billion |
|
Tongyang Inc
KO:001525
|
Korea | ₩616.60 Billion |
Liability Composition Analysis (2016–2024)
This chart breaks down Aju IB Investment Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Aju IB Investment Co. Ltd.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | N/A | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.29 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.23 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Aju IB Investment Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Aju IB Investment Co. Ltd (2016–2024)
The table below shows the annual total liabilities of Aju IB Investment Co. Ltd from 2016 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩80.58 Billion ≈ $54.61 Million |
-16.15% |
| 2023-12-31 | ₩96.11 Billion ≈ $65.13 Million |
-25.99% |
| 2022-12-31 | ₩129.85 Billion ≈ $88.00 Million |
-11.85% |
| 2021-12-31 | ₩147.32 Billion ≈ $99.83 Million |
-25.11% |
| 2020-12-31 | ₩196.71 Billion ≈ $133.31 Million |
+34.41% |
| 2019-12-31 | ₩146.36 Billion ≈ $99.18 Million |
-20.32% |
| 2018-12-31 | ₩183.67 Billion ≈ $124.47 Million |
-2.67% |
| 2017-12-31 | ₩188.71 Billion ≈ $127.88 Million |
+9.42% |
| 2016-12-31 | ₩172.46 Billion ≈ $116.87 Million |
-- |
About Aju IB Investment Co. Ltd
Aju IB Investment Co., Ltd. is a venture capital and private equity arm of AJU Corporation Co., Ltd. It specializes in mezzanine, buyouts, corporate restructuring, and all stages of venture investments in small to medium sized start-up companies in South Korea. The firm considers investments in information technology including mobile service platforms, software, semiconductor, contents, biotechno… Read more